<DOC>
	<DOCNO>NCT00824109</DOCNO>
	<brief_summary>The purpose prospective trial demonstrate safety performance Second Generation Anti-Microbial vascular graft treatment aneurysmal occlusive disease abdominal aorta .</brief_summary>
	<brief_title>Prospective , Multicenter Study Second Generation Antimicrobial Graft Abdominal Position</brief_title>
	<detailed_description />
	<mesh_term>Anti-Infective Agents</mesh_term>
	<criteria>Is 18 85 year age Is present aortoiliac occlusion ( obstruction flow ) stenosis , aortoiliac aneurysm eligible revascularization bifurcate graft Is affiliate social welfare organization system Is willing participate clinical evaluation signature inform consent Is able attend follow visit diagnostics laboratory exam require present protocol Is treat emergency Is include another investigation Is pregnant lactating , woman childbearing potential unwillint use effective form contraception duration trial Has know allergy material device use Has previous aortoiliac bypass replacement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Aneurysmal disease abdominal aorta</keyword>
	<keyword>Occlusive disease abdominal aorta</keyword>
</DOC>